Arrays can also report promoter methylation at clinically relevant loci, most notably MGMT in glioblastoma, which informs temozolomide responsiveness; although often performed by separate assays, MGMT status can be extracted from array data (56). This evidence concerns the gene MGMT and glioblastoma.